title: Increased dosage requirement and rejection after Neoral conversion in pediatric liver transplant patients.
authors.affiliation: Department of Surgery, Stanford University Medical Center, CA 94304-0126, USA.
authors.forename: S
authors.initials: S
authors.lastname: Cao
authors.forename: K L
authors.initials: KL
authors.lastname: Cox
authors.forename: W
authors.initials: W
authors.lastname: Berquist
authors.forename: S
authors.initials: S
authors.lastname: So
authors.forename: W
authors.initials: W
authors.lastname: Concepcion
authors.forename: H
authors.initials: H
authors.lastname: Monge
authors.forename: C O
authors.initials: CO
authors.lastname: Esquivel
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D016572:Cyclosporine / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D006084:Graft Rejection / Q000453:epidemiology / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D015994:Incidence; D007223:Infant; D008111:Liver Function Tests; D016031:Liver Transplantation / Q000276:immunology* / Q000502:physiology; D011241:Prednisone / Q000627:therapeutic use; D012189:Retrospective Studies
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011241:Prednisone